OATP1B1/1B3 inhibitors increase brincidofovir AUC and Cmax, may increase adverse reactions. Monitor for elevations in transaminases, bilirubin, diarrhea, or GI events.
Source: NLP:brincidofovir
2 interactions on record
OATP1B1/1B3 inhibitors increase brincidofovir AUC and Cmax, may increase adverse reactions. Monitor for elevations in transaminases, bilirubin, diarrhea, or GI events.
Source: NLP:brincidofovir
Significant changes (increase or decrease) in plasma concentrations of estrogen and progestin have been noted in some cases.
Source: NLP:drospirenone and ethinyl estradiol